Advertisement

Topics

Incyte Posts Q1 Loss On Higher R&D Expenses; Jakafi Revenues Up 37%

09:11 EDT 4 May 2017 | FinanzNachrichten

WASHINGTON (dpa-AFX) - Incyte Corp. (INCY) reported a first-quarter net loss of $187 million, or $0.96 per share, as compared to net income of $24 million, or $0.12 per share for the same period i...

Original Article: Incyte Posts Q1 Loss On Higher R&D Expenses; Jakafi Revenues Up 37%

NEXT ARTICLE

More From BioPortfolio on "Incyte Posts Q1 Loss On Higher R&D Expenses; Jakafi Revenues Up 37%"

Quick Search
Advertisement